Female Gender Predictor of All-Cause Mortality After PCI

Share this content:
Female Gender Predictor of All-Cause Mortality After PCI
Female Gender Predictor of All-Cause Mortality After PCI

THURSDAY, Dec. 29, 2016 (HealthDay News) -- Female gender is an independent predictor of all-cause mortality after percutaneous coronary intervention (PCI), according to a study published in the Jan. 15 issue of The American Journal of Cardiology.

Vijay Kunadian, M.B.B.S., M.D., from Newcastle University in the United Kingdom, and colleagues examined gender differences and predictors of all-cause mortality after PCI in patients with stable angina pectoris and acute coronary syndrome in the British Cardiovascular Intervention Society (BCIS: 368,492 patients) and the Swedish Coronary Angiography and Angioplasty Registry (SCAAR; 89,769 patients) data sets.

The researchers found that female gender was an independent predictor of all-cause mortality at 30 days and one year after PCI in the BCIS registry (odds ratios, 1.15 and 1.08, respectively). Similarly, female gender was an independent predictor of all-cause mortality at 30 days and one year in the SCAAR registry (odds ratios, 1.15 and 1.09, respectively). There was no statistically significant interaction between age and gender with all-cause mortality at 30 days (BCIS, P = 0.59; SCAAR, P = 0.40) or one year (BCIS, P = 0.11; SCAAR, P = 0.83) in either dataset.

"Despite advances in care, women compared with men continue to experience higher all-cause mortality after PCI for coronary artery disease," the authors write. "Strategies and further research are warranted to better address the management of coronary artery disease in women with possibly earlier diagnosis and more tailored treatments."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »